Pratiti Bandopadhayay

Affiliations: 
Pediatric Oncology Dana-Farber Cancer Institute, Boston, MA, United States 
Google:
"Pratiti Bandopadhayay"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Giacomini G, Piquet S, Chevallier O, et al. (2024) Aberrant DNA repair reveals a vulnerability in histone H3.3-mutant brain tumors. Nucleic Acids Research
Hofman DA, Ruiz-Orera J, Yannuzzi I, et al. (2023) Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Molecular Cell
Koschmann C, Al-Holou WN, Alonso MM, et al. (2023) A road map for the treatment of pediatric diffuse midline glioma. Cancer Cell
Hofman DA, Ruiz-Orera J, Yannuzzi I, et al. (2023) Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Biorxiv : the Preprint Server For Biology
Blandin AF, Giglio R, Graham MS, et al. (2023) ALK amplification and rearrangements are recurrent targetable events in congenital and adult glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Rheinbay E, Nielsen MM, Abascal F, et al. (2023) Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature
Tsai JW, Choi JJ, Ouaalam H, et al. (2022) Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment. Neuro-Oncology Advances. 5: vdac182
Selt F, Sigaud R, Valinciute G, et al. (2022) BH3 mimetics targeting BCL-XL impact the senescent compartment of pilocytic astrocytoma. Neuro-Oncology
Coy S, Wang S, Stopka SA, et al. (2022) Single cell spatial analysis reveals the topology of immunomodulatory purinergic signaling in glioblastoma. Nature Communications. 13: 4814
Tsai JW, Cejas P, Wang DK, et al. (2022) FOXR2 is an epigenetically regulated pan-cancer oncogene that activates ETS transcriptional circuits. Cancer Research
See more...